WebbFlexible, robust and rapid IRT solution for an international infectious disease trial ICON was tasked with providing IRT services on a vaccine trial for an infectious disease. The multi-national trial included a patient population of over 30,000 subjects in over 100 locations, presenting technical, practical and logistical challenges. Webb10 feb. 2016 · OCEANSIDE, CA--(Marketwired - February 08, 2016) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Company has licensed their Exosome Patent to MolecuVax, Inc. ("MVAX") a wholly owned subsidiary of Therapeutic Solutions International, Inc. ("TSI") where the intellectual property owned by TSI …
Therapeutic Solutions International Inc (TSOI): complete opposite …
Webb20 apr. 2024 · Thursday, April 13, 2024 1:13:31 PM. Post # of 57459. sometimes, even though a flattened out technical chart may indicate a potential bottom, it doesn't guarantee a rebound in stock price. Additionally, the conversion of patents into revenue is not always a straightforward process and may take time and resources to accomplish. Webb12 apr. 2024 · Therapeutic Solutions International, Inc. engages in the manufacture of surgical and medical devices. It develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal... fit \u0026 active snack packs
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. : Amendments …
WebbOCEANSIDE, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today new data and the filing of a patent application covering the ability of NanoStilbene™ [1] and its active ingredient, pterostilbene, at accelerating recovery of blood cells after treatment with … WebbEmvolio is developing products that can be used together to attack cancer at different levels, as well as be used alone or in combination with existing therapies Webb9 aug. 2024 · ELK CITY, Idaho, Aug. 9, 2024 /PRNewswire/ -- Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today successful completion of a series of preclinical experiments requested ... fit \u0026 active snacks